{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:46:32Z","timestamp":1792511192020,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.103095","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:54:53Z","timestamp":1791384893000},"page":"103095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A standardized patient-derived glioblastoma organoid platform for evaluating radiotherapy efficacy and overcoming resistance"],"prefix":"10.1016","volume":"7","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusha","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithvi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen H.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riki","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ling-Lin Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Gubbiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Colbourn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nduka M.","family":"Amankulor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay F.","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacLean P.","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Bagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zev A.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"O\u2019Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-li","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8720-5310","authenticated-orcid":false,"given":"Hongjun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103095_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib2","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103095_bib3","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1158\/2159-8290.CD-19-0329","article-title":"The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation","volume":"9","author":"Wang","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103095_bib4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib5","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","article-title":"A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets","volume":"3","author":"Wang","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.103095_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.wneu.2018.04.022","article-title":"Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance","volume":"116","author":"Noch","year":"2018","journal-title":"World Neurosurg."},{"key":"10.1016\/j.xcrm.2026.103095_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103095_bib8","article-title":"Factors affecting the radiation response in glioblastoma","volume":"4","author":"Aiyappa-Maudsley","year":"2022","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.xcrm.2026.103095_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/neuonc\/nop020","article-title":"MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma","volume":"12","author":"Rivera","year":"2010","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib10","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","article-title":"Glioma progression is shaped by genetic evolution and microenvironment interactions","volume":"185","author":"Varn","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib11","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1158\/0008-5472.CAN-14-3790","article-title":"Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells","volume":"75","author":"Ahmed","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103095_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103095_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib14","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","article-title":"A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo","volume":"76","author":"Hubert","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103095_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid Cultures Derived from Patients with Advanced Prostate Cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib16","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett\u2019s Epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.103095_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid Models of Human and Mouse Ductal Pancreatic Cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib20","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","article-title":"Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening","volume":"10","author":"Kim","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103095_bib21","article-title":"Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.103095_bib22","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.stem.2024.08.010","article-title":"The landscape of drug sensitivity and resistance in sarcoma","volume":"31","author":"Al Shihabi","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.stem.2022.04.006","article-title":"Patient-derived micro-organospheres enable clinical precision oncology","volume":"29","author":"Ding","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/oons\/kvad008","article-title":"Glioblastoma modeling with 3D organoids: progress and challenges","volume":"2","author":"Wang","year":"2023","journal-title":"Oxf. Open Neurosci."},{"key":"10.1016\/j.xcrm.2026.103095_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccell.2022.02.016","article-title":"Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity","volume":"40","author":"LeBlanc","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib26","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.stem.2025.01.002","article-title":"Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy","volume":"32","author":"Peng","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.stem.2024.11.010","article-title":"Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy","volume":"32","author":"Logun","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41586-025-08634-7","article-title":"Brain-wide neuronal circuit connectome of human glioblastoma","volume":"641","author":"Sun","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103095_bib29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/neuonc\/noaf007","article-title":"Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology","volume":"27","author":"Deligne","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib30","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/neuonc\/noag085","article-title":"Modeling Gliomas with Organoids: Classification, Fidelity, and Guidelines for Translational Neuro-Oncology","volume":"28","author":"Hubert","year":"2026","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/cells12030360","article-title":"Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines","volume":"12","author":"Raitanen","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.103095_bib32","doi-asserted-by":"crossref","first-page":"e2492","DOI":"10.1038\/cddis.2016.360","article-title":"Large-scale pharmacological profiling of 3D tumor models of cancer cells","volume":"7","author":"Mathews Griner","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.103095_bib33","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/stem.15","article-title":"Neurosphere formation is an independent predictor of clinical outcome in malignant glioma","volume":"27","author":"Laks","year":"2009","journal-title":"Stem Cell."},{"key":"10.1016\/j.xcrm.2026.103095_bib34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/neuonc\/now304","article-title":"The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response","volume":"19","author":"D\u2019Alessandris","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib35","article-title":"Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma.","volume":"7","author":"Park","year":"2026","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.103095_bib36","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal bivalent CAR T cells targeting EGFR and IL13R\u03b12 in recurrent glioblastoma: phase 1 trial interim results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103095_bib37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1158\/2159-8290.CD-13-0879","article-title":"EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing","volume":"4","author":"Francis","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103095_bib38","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/neuonc\/now113","article-title":"EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation","volume":"18","author":"Eskilsson","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib39","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","article-title":"UCell: Robust and scalable single-cell gene signature scoring","volume":"19","author":"Andreatta","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.xcrm.2026.103095_bib40","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2007.14.8163","article-title":"MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients","volume":"26","author":"Brandes","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.103095_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109485","article-title":"DKK1 affects survival of patients with head and neck squamous cell carcinoma by inducing resistance to radiotherapy and immunotherapy","volume":"181","author":"Ye","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13148-019-0695-0","article-title":"Clustered protocadherins methylation alterations in cancer","volume":"11","author":"Vega-Benedetti","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.xcrm.2026.103095_bib45","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103095_bib46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal Differentiation Mediated by NF-\u03baB Promotes Radiation Resistance in Glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib47","article-title":"Targeting extracellular matrix remodeling sensitizes glioblastoma to ionizing radiation","volume":"4","author":"Thakur","year":"2022","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.xcrm.2026.103095_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2026.103095_bib48","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a Cancer Dependency Map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib49","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib50","doi-asserted-by":"crossref","first-page":"ec248","DOI":"10.1126\/scisignal.aal2473","article-title":"Kinase inhibitors that block bromodomain interactions","volume":"9","author":"Mushegian","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2026.103095_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.818891","article-title":"A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles","volume":"13","author":"Ali","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.103095_bib52","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1093\/neuonc\/noaf169","article-title":"BRD2 bromodomain-mediated regulation of cell state plasticity modulates therapy response in glioblastoma","volume":"27","author":"Vadla","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib53","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/neuonc\/noab115","article-title":"BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma","volume":"23","author":"Gusyatiner","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib54","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/onc.2014.291","article-title":"Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies","volume":"34","author":"Du","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.103095_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib56","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41591-022-01717-2","article-title":"Delivering precision oncology to patients with cancer","volume":"28","author":"Mateo","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103095_bib57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","article-title":"Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines","volume":"9","author":"Lee","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib58","doi-asserted-by":"crossref","first-page":"69185","DOI":"10.18632\/oncotarget.20193","article-title":"Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries?","volume":"8","author":"Ledur","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2026.103095_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1862","article-title":"Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns","volume":"6","author":"Salvadores","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.103095_bib60","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ccell.2021.07.020","article-title":"Tumor organoids: Opportunities and challenges to guide precision medicine","volume":"39","author":"Veninga","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103095_bib61","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tibtech.2017.12.005","article-title":"Personalized Cancer Medicine: An Organoid Approach","volume":"36","author":"Aboulkheyr Es","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103095_bib62","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2026.103095_bib63","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.celrep.2019.02.063","article-title":"Modeling Patient-Derived Glioblastoma with Cerebral Organoids","volume":"26","author":"Linkous","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103095_bib64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.15252\/emmm.201505890","article-title":"MET inhibition overcomes radiation resistance of glioblastoma stem-like cells","volume":"8","author":"De Bacco","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103095_bib65","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1269\/jrr.09077","article-title":"Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1\/Ref-1","volume":"51","author":"Naidu","year":"2010","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.xcrm.2026.103095_bib66","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/life11050451","article-title":"Ionizing Radiation Induces Resistant Glioblastoma Stem-Like Cells by Promoting Autophagy via the Wnt\/\u03b2-Catenin Pathway","volume":"11","author":"Tsai","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.xcrm.2026.103095_bib67","first-page":"2166","article-title":"Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis","volume":"6","author":"Huang","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103095_bib68","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus Radiotherapy\u2013Temozolomide for Newly Diagnosed Glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103095_bib69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1593\/tlo.12364","article-title":"Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule","volume":"6","author":"Kuger","year":"2013","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib70","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103095_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106767","article-title":"BRD4: New hope in the battle against glioblastoma","volume":"191","author":"Duan","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2026.103095_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2021.03.005","article-title":"BRD4: An emerging prospective therapeutic target in glioma","volume":"21","author":"Yang","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.xcrm.2026.103095_bib73","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41419-022-05497-y","article-title":"BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression","volume":"13","author":"Tancredi","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.103095_bib74","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174794","article-title":"BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma","volume":"134","author":"Watanabe","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103095_bib75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2017.01.031","article-title":"The BET bromodomain inhibitor JQ1 radiosensitizes non-small cell lung cancer cells by upregulating p21","volume":"391","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2026.103095_bib76","article-title":"BRD4-IRF1 axis regulates chemoradiotherapy-induced PD-L1 expression and immune evasion in non-small cell lung cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103095_bib77","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/j.ygyno.2024.07.350","article-title":"Targeting BRD4 with BET inhibition synergizes with anti-HER2 therapy and overcomes resistance in HER2-amplified uterine serous cancer","volume":"190","author":"Mahira","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177652","article-title":"Synergistic effects of BET inhibitors and ferroptosis inducers via targeted inhibition of the BRD4\/c-Myc\/NRF2 pathway in AML","volume":"998","author":"Zhong","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.103095_bib79","doi-asserted-by":"crossref","first-page":"79217","DOI":"10.18632\/oncotarget.12640","article-title":"The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2026.103095_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2025.104250","article-title":"Protocol for high-content drug screening using tumor organoids on a 384-pillar plate platform","volume":"6","author":"Choi","year":"2025","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2026.103095_bib81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2026.103095_bib82","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.103095_bib83","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","article-title":"Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing","volume":"15","author":"Jacob","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2026.103095_bib84","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","article-title":"Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences","volume":"35","author":"Zhu","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.103095_bib85","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.xcrm.2026.103095_bib87","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103095_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2025.102534","article-title":"Cholinergic neuron-to-glioblastoma synapses in a human iPSC-derived co-culture model","volume":"20","author":"Sun","year":"2025","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103095_bib88","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.21105\/joss.01541","article-title":"bayestestR: Describing Effects and their Uncertainty, Existence and Significance within the Bayesian Framework","volume":"4","author":"Makowski","year":"2019","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.xcrm.2026.103095_bib89","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1200\/JCO.2016.70.7562","article-title":"Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline","volume":"35","author":"Sulman","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103095_bib90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2307\/2532740","article-title":"Maximally Selected Rank Statistics","volume":"48","author":"Lausen","year":"1992","journal-title":"Biometrics"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126005124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126005124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:14:48Z","timestamp":1792509288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126005124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":90,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666379126005124"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103095","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A standardized patient-derived glioblastoma organoid platform for evaluating radiotherapy efficacy and overcoming resistance","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103095"}}